Skip to main
INTS
INTS logo

Intensity Therapeutics Inc (INTS)

$0.00

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

Buy INTS Stock

About Intensity Therapeutics Inc (INTS)

Intensity Therapeutics, Inc. operates as biotechnology company, which develops novel immune-based therapeutic products for cancer treatment. Its product, INT230-6, is a formulation consisting of an amphiphilic cell penetration enhancer molecule combined with cisplatin and vinblastine. The company was founded by Lewis H. Bender in 2012 and is headquartered in Shelton, CT.
Market cap$5.85M
Today's volume1.76M
Revenue (TTM)
Avg. daily volume904.47K
EBITDA (TTM)-$15.21M
Open$0.30
Price / earnings ratio-0.30x
Today's range$0.3 - $0.33
Debt / equity39.22x
52 week range$0.28 - $5.1
5 year debt / equity3.91x
Beta (LTM)-0.43x
Interest coverage
Dividend & yield$0.00 (0.00%)
Current ratio0.63x
Ex-dividend date
Next earningsAug 7, 2025
Dividend payable date

INTS Stock Rating

What analysts recommend for INTS stock, on a scale from 1(buy) to 5(sell).
Strong Buy
Strong Buy 67%
Buy 33%
Hold 0%
Sell 0%
Strong Sell 0%

Frequently Asked Questions (FAQ)

As of Jun 15, 2025, the market cap for INTS stock is $5.86M

The current P/E ratio for INTS stock is -0.3

The 52-week high for INTS stock is $5.10. The current INTS stock price $undefined is 100.00% below its 52-week high

The 52-week low for INTS stock is $0.28. The current INTS stock price $undefined has increased 100.00% from its 52-week low

No, the INTS stock does not pay dividends to its shareholders

The target price for INTS stock is $8.50 based on the average of what a group of analyst think INTS stock could be worth at a future date. This is not a prediction by Public.com

How to buy INTS stock on Public

  1. 1

    Sign up for a brokerage account on Public

    It’s easy to get started. You can sign up for an account directly on our website or by downloading the Public app for iOS or Android.

  2. 2

    Add funds to your Public account

    There are multiple ways to fund your Public account—from linking a bank account to making a deposit with a debit card or wire transfer.

  3. 3

    Choose how much you'd like to invest in INTS stock

    Navigate to the Explore page. Then, type INTS into the search bar. When you see INTS stock appear in the results, tap it to open up the purchase screen.

  4. 4

    Manage your investments in one place

    You can find your newly purchased INTS stock in your portfolio—alongside the rest of your stocks, ETFs, crypto, treasuries, and alternative assets.

Intensity Therapeutics Inc Stock Earnings

The value each INTS share was expected to gain vs. the value that each INTS share actually gained.

INTS (INTS) reported Q1 2025 earnings per share (EPS) of -$0.22, missing estimates of -$0.13 by 69.23%. In the same quarter last year, INTS's earnings per share (EPS) was -$0.34. INTS is expected to release next earnings on 08/07/2025, with an earnings per share (EPS) estimate of $0.

Buy INTS Stock

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.